Skip to main content
Premium Trial:

Request an Annual Quote

ACD/Labs, eMolecules, Waters, Symyx, Exagen, Bayer CropScience, AurScope

Premium
ACD/Labs, eMolecules to Integrate LogP Predictions With Chemical Structure Database
 
Chemistry database provider eMolecules and Advanced Chemistry Development said they have agreed to integrate predicted logP data from ACD/Labs’ software with eMolecules’ freely available chemical structure search engine.
 
ACD/Labs’ logP Batch software, which predicts the lipophilicity of molecules, will be integrated into the search engine.
 
The addition of lipophilicity predictions is expected to enable “more efficient selection and procurement of chemical structures,” the companies said in a statement.
 

 
Waters to Integrate NuGenesis SDMS With Symyx Electronic Lab Notebook
 
Waters and Symyx Technologies said this week that they have agreed to integrate Waters’ NuGenesis Scientific Data Management System with the Symyx Electronic Lab Notebook.
 
Following the integration, scientists using the Symyx ELN software will be able to directly retrieve data and documents stored in NuGenesis SDMS, “saving considerable time and effort,” the companies said.
 

 
Exagen Files for FDA Clearance of Breast Cancer Prognostic Kit
 
Exagen Diagnostics said this week that it has filed for US Food and Drug Administration review of its DNA-based test for identifying risk of recurrence in breast cancer patients.
 
The company developed the test, called eXagenBC, using a proprietary computational method that the company claims enables it to discover sets of predictive genes and develop a diagnostic test within two months, compared to two to three years for other approaches [BioInform 02-09-07].  
 
The company’s software identifies much smaller sets of genes than those used for other gene-based breast cancer prognostics, such as Genomic Health’s Oncotype Dx, which uses 21 genes, and Agendia’s MammaPrint, which uses 70 genes.
 
Compared to microarray-based diagnostics, these smaller biomarker panels, which comprise around two to three genes, “can be performed and analyzed at any qualified laboratory, resulting in lower costs, reduced complexity, and faster turn-around time of results for physicians and patients,” the company said in a statement.
 

 
Bayer CropScience Licenses AurScope Databases
 
Aureus Pharma said this week that Bayer CropScience has licensed several AurScope knowledge databases and software packages.
 
The company did not provide details on the products licensed under the agreement.
 

 
Malaysian Genome Resource Center, Regional University Pen Bioinformatics-Training Alliance
 
The Malaysian Genome Resource Center and a state-owned university in the region will form a bioinformatics research initiative aimed at enhancing the school’s bioinformatics programs, the MGRC said this week.
 
Under the collaboration, the MGRC will work with Selangor-based Unisel so that its SynaBase software can support the school’s Bachelor of Bioinformatics program.

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.